Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis

Title
Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis
Authors
Keywords
GFAP, Biomarker, Alzheimer's disease, Mild cognitive impairment, Inflammation, Apoptosis
Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 361, Issue -, Pages 577744
Publisher
Elsevier BV
Online
2021-10-12
DOI
10.1016/j.jneuroim.2021.577744

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started